文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

柴胡多糖诱导晚期脓毒症免疫逆转

Polysaccharides from Bupleurum Induce Immune Reversal in Late Sepsis.
PubMed 文献 · Shock · 2018-01-01
一句话结论小鼠烧伤铜绿假单胞菌脓毒症模型中,柴胡多糖剂量依赖性降低死亡率,并增加骨髓和肝脏CD11cCD45RB树突状细胞及骨髓细胞数量。

该研究为动物实验,将BALB/c小鼠分为假烧伤组、烧伤加铜绿假单胞菌组及烧伤加铜绿假单胞菌予柴胡多糖(40 mg/kg、100 mg/kg、250 mg/kg)治疗组,于烧伤后第0、3、5、7天处死取材。柴胡多糖剂量依赖性降低烧伤脓毒症小鼠死亡率,显著增加骨髓和肝脏CD11cCD45RB树突状细胞百分比及骨髓细胞和肝细胞数量。在烧伤后第7天,骨髓细胞、肝细胞及CD11cCD45RB树突状细胞过继治疗可保护脓毒症小鼠。作者认为柴胡多糖可能通过骨髓细胞免疫再分布,尤其通过骨髓和非免疫器官中CD11cCD45RB树突状细胞分化,诱导晚期脓毒症免疫逆转,从而改善预后。

要点

  • 在小鼠烧伤铜绿假单胞菌脓毒症模型中,柴胡多糖(40 mg/kg、100 mg/kg、250 mg/kg)剂量依赖性降低死亡率。
  • 柴胡多糖显著增加骨髓和肝脏中CD11cCD45RB树突状细胞百分比,并显著增加骨髓细胞和肝细胞数量。
  • 烧伤后第7天给予骨髓细胞、肝细胞或CD11cCD45RB树突状细胞过继治疗,可保护脓毒症小鼠。
  • 作者认为柴胡多糖可能通过骨髓细胞免疫再分布,尤其通过CD11cCD45RB树突状细胞分化,诱导晚期脓毒症免疫逆转。

适用人群与场景

  • BALB/c小鼠,烧伤后铜绿假单胞菌脓毒症模型;分为假烧伤组、烧伤加铜绿假单胞菌组及三个柴胡多糖剂量治疗组。

处置流程与药物剂量

  • 柴胡多糖按40 mg/kg、100 mg/kg、250 mg/kg给药(原文未写明给药途径、频次和疗程)。
  • 于烧伤后第0、3、5、7天处死小鼠,采集骨髓细胞、肝细胞和树突状细胞。
  • 烧伤后第7天给予骨髓细胞、肝细胞或CD11cCD45RB树突状细胞过继治疗。

研究设计与关键结果

  • 研究类型为动物实验;样本为BALB/c小鼠,分五组:假烧伤组、烧伤加铜绿假单胞菌组及烧伤加铜绿假单胞菌予柴胡多糖40 mg/kg、100 mg/kg、250 mg/kg治疗组,于烧伤后第0、3、5、7天处死。
  • 柴胡多糖剂量依赖性降低烧伤脓毒症小鼠死亡率,并显著增加骨髓和肝脏CD11cCD45RB树突状细胞百分比及骨髓细胞和肝细胞数量。
  • 烧伤后第7天给予骨髓细胞、肝细胞或CD11cCD45RB树突状细胞过继治疗,可保护脓毒症小鼠。

证据类型、等级与局限

  • 证据类型:动物实验(BALB/c小鼠)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为柴胡多糖可能通过骨髓细胞免疫再分布,尤其通过骨髓和非免疫器官中CD11cCD45RB树突状细胞分化,诱导晚期脓毒症免疫逆转,从而促进烧伤后脓毒症预后;该结论来自小鼠实验,原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Bupleurum chinense, a well-known Traditional Chinese Medicine, has been used for thousands of years in China. In this study, we would suggest that Bupleurum polysaccharides (BPS) could improve the prognosis of sepsis through its impact on redistribution of BMCs, which triggers immune reversal in late sepsis.

METHODS: BALB/c mice were divided into five groups: sham burn group, burn plus P aeruginosa group, burn plus P aeruginosa with BPS (40 mg/kg, 100 mg/kg, and 250 mg/kg) treatment group, and they were sacrificed at post-burn day (PBD) 0, 3, 5, and 7. BMCs, liver cells, and dendritic cells (DCs) were harvested. Flow cytometry was used to determine the change of phenotypes of DCs and isolate these cells. Cytometric beads array was utilized to analyze the level of inflammatory factors. Cell therapy of BMCs, liver cells, and DCs was administrated to explore the protective role of regional organ immunity.

RESULTS: BPS could decrease the lethality of burn sepsis in a dose-dependent fashion and increase both the percentage of CD11cCD45RB DCs in bone marrow (BM) and liver and the number of BMCs and liver cells significantly. Cell therapy of BMCs, liver cells, and CD11cCD45RB DCs at PBD7 could protect septic mice from sepsis.

CONCLUSION: BPS has shown its potential in promoting the prognosis of post-burn sepsis through its effect on immune redistribution of BMCs, especially via differentiation of CD11cCD45RB DC cells in BM and nonimmune organs to induce immune reversal in late sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wang YX, Liu QY, Zhang M, et al. Polysaccharides from Bupleurum Induce Immune Reversal in Late Sepsis. Shock. 2018. PMID: 28658005. doi:10.1097/SHK.0000000000000934

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。